These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 20108775

  • 21. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM, Mendoza Montero J, Expósito Hernández J, Salinero Hernández J, Esquivias López-Cuerpo J, Ballesteros García P.
    Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136
    [Abstract] [Full Text] [Related]

  • 22. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma].
    Mendoza J, Rojas A, de la Rosa M, Amador JM, Expósito J, Esquivias J.
    Med Clin (Barc); 1991 Nov 09; 97(16):609-11. PubMed ID: 1662737
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):130-7. PubMed ID: 16979842
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Jan 01; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 25. [Improve on serological diagnosis method of nasopharyngeal carcinoma].
    Zhan SB, Zhong JM, Mai ZP, Ye SQ, Zhou L, Zeng Y, Liao J.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb 01; 23(1):65-7. PubMed ID: 19799023
    [Abstract] [Full Text] [Related]

  • 26. Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma.
    Kumar S, Wairagkar NS, Mahanta J.
    Indian J Cancer; 2001 Feb 01; 38(2-4):72-5. PubMed ID: 12593442
    [Abstract] [Full Text] [Related]

  • 27. Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
    Zhang WR, Du YY, Guo CY, Zhou HX, Lin JY, Meng XH, Mo HY, Luo DH.
    Cancer Res Treat; 2021 Oct 01; 53(4):991-1003. PubMed ID: 33494127
    [Abstract] [Full Text] [Related]

  • 28. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma.
    Luo YL, Ou GP, Chi PD, Liang YN, Liu YH, Huang MY.
    Ai Zheng; 2009 Jan 01; 28(1):76-8. PubMed ID: 19448423
    [Abstract] [Full Text] [Related]

  • 29. Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.
    Mao MJ, Xue N, Wang XP, Chi PD, Liu YJ, Huang Q, Dai SQ, Liu WL.
    BMC Cancer; 2018 Jan 02; 18(1):9. PubMed ID: 29295705
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
    Tang JW, Rohwäder E, Chu IM, Tsang RK, Steinhagen K, Yeung AC, To KF, Chan PK.
    J Clin Virol; 2007 Dec 02; 40(4):284-8. PubMed ID: 17977062
    [Abstract] [Full Text] [Related]

  • 31. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
    Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, Chang AR, van Hasselt CA, Huang DP, To KF.
    Clin Cancer Res; 2002 Aug 02; 8(8):2612-9. PubMed ID: 12171892
    [Abstract] [Full Text] [Related]

  • 32. Serological diagnosis of nasopharyngeal carcinoma by enzyme linked immunosorbent assay: optimization, standardization and diagnostic criteria.
    Ng MH, Chen HL, Luo RX, Chan KH, Woo PC, Sham JS, Huang J, Seto WH, Smith P, Griffin BE.
    Chin Med J (Engl); 1998 Jun 02; 111(6):531-6. PubMed ID: 11245074
    [Abstract] [Full Text] [Related]

  • 33. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug 02; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 34. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma.
    Jiang SQ, Liu Q.
    Ai Zheng; 2009 Feb 02; 28(2):177-80. PubMed ID: 19550133
    [Abstract] [Full Text] [Related]

  • 35. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum.
    Cheng WM, Chan KH, Chen HL, Luo RX, Ng SP, Luk W, Zheng BJ, Ji MF, Liang JS, Sham JS, Wang DK, Zong YS, Ng MH.
    Int J Cancer; 2002 Feb 01; 97(4):489-92. PubMed ID: 11802211
    [Abstract] [Full Text] [Related]

  • 36. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

  • 37. Increasing the accuracy and scalability of the Immunofluorescence Assay for Epstein Barr Virus by inferring continuous titers from a single sample dilution.
    Goh SM, Swaminathan M, Lai JU, Anwar A, Chan SH, Cheong I.
    J Immunol Methods; 2017 Jan 20; 440():35-40. PubMed ID: 27983956
    [Abstract] [Full Text] [Related]

  • 38. Diagnostic value of Epstein-Barr viral serology in nasopharyngeal carcinoma.
    Low WK, Leong JL, Goh YH, Fong KW.
    Otolaryngol Head Neck Surg; 2000 Oct 20; 123(4):505-7. PubMed ID: 11020195
    [Abstract] [Full Text] [Related]

  • 39. Novel Epstein-Barr virus immunoglobulin G-based approach for the specific detection of nasopharyngeal carcinoma.
    Abdulamir AS, Hafidh RR, Abu Bakar F, Abbas K.
    Am J Otolaryngol; 2010 Oct 20; 31(6):410-7. PubMed ID: 20015794
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
    Liu MY, Chang YL, Ma J, Yang HL, Hsu MM, Chen CJ, Chen JY, Yang CS.
    J Med Virol; 1997 Jul 20; 52(3):262-9. PubMed ID: 9210034
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.